This site uses cookies to collect activity data and personalize content. By continuing to navigate this site, you agree to allow us to collect information using cookies. Learn more about how we care for your data in our privacy notice.

Accept
Pandemic response
COVID-19 is impacting communities around the world. PATH and our partners are responding.

RSV Clinical Trial Tracker

This spreadsheet provides publicly available information on clinical trials of respiratory syncytial virus (RSV) candidate vaccines and monoclonal antibodies intended for prevention. Sources of information for these trials are clinicaltrials.gov; who.int/ctrp; clinicaltrialsregister.eu; and anzctr.org.au, which includes clinical trial registries from 17 countries. Some information is also obtained through contact with investigators, sponsors, and funders of vaccine trials. (This spreadsheet pairs with the RSV Vaccine and mAb Snapshot, which provides a summary of the RSV vaccine and mAb candidates in development worldwide.)

Publication date: March 2020

RSV Clinical Trial Tracker

186.5 KB XLSX

View Resource